JSE Daily Intelligence

JSE Tuesday: Resources Lead as All Share Gains 1.40%

South African equities rallied broadly on Tuesday, with the All Share closing 1.40% higher as resources and financials led the charge. The Resource 20 surged 2.96%.

What we are watching

Investors should watch for NEPI Rockcastle's H1 results presentation on 19 August, which will be the first opportunity to assess property sector performance for the half-year, while Sanlam releases its full H1 2026 results under the new operating profit framework on 10 September.

South African equities rallied broadly on Tuesday, with the All Share closing 1.40% higher as resources and financials led the charge. The Resource 20 surged 2.96% and the FTSE/JSE Basic Materials index added 2.91%, while the Top 40 gained 1.56%. The JSE's own earnings beat added a self-referential positive note to the session, though telecoms and chemicals lagged. In thin trade, Sasol's BEE line (SOLBE1) spiked 20.31% without a specific news catalyst, while Labat Africa shed a third of its value on no disclosed cause.

JSE Exchange delivers 18.8% HEPS beat on cost discipline and cash generation

JSE Limited reported unreviewed H1 2026 interim results showing headline earnings per share growing 18.8% to 816.2 cents, a double-digit acceleration that outpaced inflation and reflected genuine operating momentum rather than one-off items. The EBITDA margin expanded one percentage point to 43.1% even after absorbing R44.5 million in once-off redesign costs, signalling that the exchange's cost discipline is yielding durable margin improvement. Capital Markets and Post-Trade Services drove the beat, with operating leverage of 3.1% meaning trading revenues are growing faster than the cost base. Operating cash flow rose 20.6% to R625 million, comfortably outpacing the 16.9% net profit after tax gain and reinforcing a cash and bond position of R2.6 billion. The sole drag was the JIS segment, where revenue fell 5.6% on lower interest rates and subdued corporate action activity. No interim dividend was declared, and the figures are unreviewed — the audited results will be the next test of whether the margin expansion holds. The share had sold off into the print with a CAR-20 of -5.7%, so Tuesday's numbers landed as a genuine positive surprise rather than confirmation of elevated expectations.

ISO ASP Isotopes shareholder letter lifts veil on Phase 1 run-rate and Phase 2 debt commitment

ASP Isotopes issued a shareholder letter on Tuesday disclosing quantitative guidance the market had not previously had on record, providing the first concrete benchmarks for Phase 1 execution and Phase 2 funding. PET Labs is forecast to earn approximately $14 million in FY2026, up from $6 million in 2025, while Renergen's Phase 1 is targeting an annualised revenue run-rate of roughly $27 million, supported by an offtake agreement priced above $600 per thousand cubic feet for approximately 15% of Phase 1 helium. Phase 2 has a disclosed $750 million senior debt commitment from the US DFC and Standard Bank, subject to entering binding definitive agreements — representing a 13-times scale-up of the Phase 1 plant. A 2031 EBITDA table projecting $330 million to $700 million was also provided, though without GAAP reconciliation and with management citing unavailability of reliable estimates for selling prices and production costs. The share had sold off materially into the print at CAR-20 of -15.6%, near its 52-week low, making these disclosures genuine news rather than confirmation. Equipment failures at Klydon and a laser outage in H2 2025 are documented in the filing, and the Phase 2 debt remains conditional — Q2 actuals and a funding-closing confirmation are what the market will need before fully crediting the narrative.

XII Numeral swings to Q1 loss as cost growth outpaces flat revenue

Numeral Limited reported Q1 FY2027 results that swung to a headline loss per share of (0.0047) USD from a prior-year profit of 0.0230 USD — a 120.43% reversal — against a marginal 0.93% revenue decline. The mismatch between sub-1% top-line contraction and a 7.5% fall in operating profit to USD 356,627 points to cost growth running well ahead of revenue, a combination that raises structural questions about the business model. Operating profit remained positive in absolute terms and the per-share impact is small, but the direction is unambiguously negative. The figures are unaudited, delivered in short-form with only four income statement lines and no balance sheet, cash flow or segment detail, leaving the market unable to diagnose whether this is a one-quarter blip or a systemic margin problem. Prior-year comparatives have been restated and will continue to be restated until 28 February 2027, further undermining the reliability of the year-on-year baseline. The market will need the full results package and management commentary to assess the cause and durability of the deterioration.

OAO Oando H1 2026: operational beats visible but share had already rallied 44% into the print

Oando reported H1 2026 unaudited results showing production growth of 16% and a unit cost reduction of 18%, with operating cash swinging sharply positive at N179.5 billion. Headline profit after tax rose 8%, though this figure was flattered by a N55.9 billion impairment reversal and a N101 billion net tax credit — without those items, the underlying improvement is more modest. The corporate facility and medium-term loan were restructured and are in good standing, and a US$1.5 billion multi-instrument issuance programme alongside a rights issue is advancing, which together represent a meaningful expansion of the capital base. FY2026 traded crude guidance was revised downward to 22–26 million barrels after one marketing programme was impacted by NNPC's new crude-backed financing structure, and management flagged an intensive fundraising and balance sheet restructuring programme ahead. The critical caveat for SA retail investors is that the share had run up 44% in the 20 trading days before publication, meaning a substantial portion of the good news was already priced in before the announcement hit the market. The capital restructuring and rights issue to come are the variables that will determine whether the balance sheet repair comes at a cost to ordinary shareholders.

NED Nedbank H1: flat headline earnings hide 12% ex-ETI underlying growth as credit quality worsens

Nedbank Group reported unaudited H1 2026 interim results with headline earnings essentially flat at +0.1%, but stripping out the disposed ETI associate, underlying headline earnings growth was a substantive 12% on revenue up 6% to R38.2 billion — a positive jaws outcome with expenses contained at just 3%. Return on equity of 15.0% remained above the group's 14.0% cost of equity, and an interim dividend of 1,052 cents per share was declared, up 2% on the prior year. The NCBA offer closed with 79.9% shareholder acceptance, achieving the targeted 66% shareholding, with remaining regulatory approvals expected end-Q3 or early-Q4 2026 — a clear diversification catalyst for the group. The offsetting concerns are real: the credit loss ratio worsened to 95 basis points from 81 basis points, a 14 basis point jump in impairments that signals rising asset-quality risk, and the CET1 ratio fell to 12.6% from 13.1%, narrowing capital headroom as the NCBA acquisition awaits final sign-off. Diluted HEPS rose 2% while headline earnings grew only 0.1%, revealing that per-share growth was partly buyback-driven rather than purely operational. A bank that earns more but lends less reliably is not a clean story, and the market will scrutinise H2 for evidence that the credit cycle is stabilising.

Frequently asked

How did the JSE perform on Tuesday 4 August 2026?

The All Share closed 1.40% higher. The Resource 20 led sectoral gains at +2.96%, with basic materials up 2.91% and industrial metals and mining up 3.45%. Telco and chemicals lagged.

What did JSE Limited report in H1 2026?

JSE Limited reported unreviewed H1 2026 results with HEPS up 18.8% to 816.2 cents. EBITDA margin expanded 1pt to 43.1% and operating cash flow rose 20.6% to R625m. No interim dividend was declared.

Why did ASP Isotopes shares move on Tuesday?

ASP Isotopes issued a shareholder letter disclosing new quantitative guidance: PET Labs targets $14m FY2026 revenue, Renergen's Phase 1 targets a $27m annualised revenue run-rate, and Phase 2 has a disclosed $750m senior debt commitment from US DFC and Standard Bank.

What is behind Nedbank's mixed H1 2026 results?

Nedbank reported flat headline earnings (+0.1%) but 12% underlying HE growth ex-ETI on revenue up 6% to R38.2bn. The credit loss ratio worsened to 95 bps from 81 bps, and CET1 fell to 12.6% from 13.1%, raising asset-quality and capital concerns alongside the positives.